Illumina Appoints New Directors, Updates CFO Employment Agreement
Ticker: ILMN · Form: 8-K · Filed: 2025-03-24T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, executive-compensation, management-changes
Related Tickers: ILMN
TL;DR
Illumina adds two directors and signs a new deal with its CFO.
AI Summary
On March 18, 2025, Illumina, Inc. announced changes in its board of directors and executive compensation. The company elected two new directors, Dr. David L. R. Smith and Ms. Susan J. Henry, to its Board, effective March 18, 2025. Additionally, the company entered into a new employment agreement with its Chief Financial Officer, Arthur M. Leach, effective March 18, 2025, detailing his compensation.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board and executive roles can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- Dr. David L. R. Smith (person) — Newly elected director
- Ms. Susan J. Henry (person) — Newly elected director
- Arthur M. Leach (person) — Chief Financial Officer
- March 18, 2025 (date) — Effective date of director appointments and CFO agreement
FAQ
Who were the new directors elected to Illumina's Board?
Dr. David L. R. Smith and Ms. Susan J. Henry were elected as new directors to Illumina's Board.
When were the new directors' appointments effective?
The appointments of Dr. David L. R. Smith and Ms. Susan J. Henry were effective March 18, 2025.
What is the name of Illumina's Chief Financial Officer?
Arthur M. Leach is the Chief Financial Officer of Illumina.
What significant event occurred regarding the CFO on March 18, 2025?
Illumina entered into a new employment agreement with its Chief Financial Officer, Arthur M. Leach, effective March 18, 2025.
What type of filing is this report?
This filing is a Form 8-K Current Report.
From the Filing
0001110803-25-000029.txt : 20250324 0001110803-25-000029.hdr.sgml : 20250324 20250324170214 ACCESSION NUMBER: 0001110803-25-000029 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250318 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250324 DATE AS OF CHANGE: 20250324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 25764958 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20250318.htm 8-K ilmn-20250318 0001110803 FALSE 0001110803 2025-03-24 2025-03-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form  8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 )  202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐      If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o      Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 18, 2025, Carissa Rollins, Chief Information Officer, notified Illumina, Inc. that she will be retiring effective as of April 11, 2025. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.           ILLUMINA, INC.   Date: March 24,